MedTrace Logo

Stent Placement and the Risk of New-onset AF in Patients With AMI

NCT03382990 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40000

Last updated 2017-12-26

No results posted yet for this study

Summary

The benefit of a drug-eluting stent (DES) in patients with acute myocardial infarction (AMI) is controversial. This study will aim to observe the effect of a DES on the risk of new-onset AF in patients with AMI.

Conditions

  • Atrial Fibrillation New Onset
  • Acute Myocardial Infarction

Interventions

DEVICE

DES or BMS

DES or BMS placement during the procedure of PCI in patients with AMI is depend on the operator's decision.

Sponsors & Collaborators

  • Mackay Memorial Hospital

    lead OTHER

Principal Investigators

  • Li-Nien Chien, PhD · Taipei Medical University

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-12-31
Completion
2019-12-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03382990 on ClinicalTrials.gov